To examine the association between serum magnesium levels and C-reactive protein (CRP) in non-diabetic, nonhypertensive obese subjects. DESIGN: Cross-sectional study. SUBJECTS: A total of 371 subjects, 101 men and 270 women. Of them 138 lean (37.2%), 133 (35.9%) overweight, and 100 (26.9%) were obese, matched by age. MEASUREMENTS: Fasting and 2 h serum glucose following a 75 g oral glucose load. Fasting serum total cholesterol, HDL-and LDL-cholesterol, triglycerides, C-reactive protein (CRP), albumin; and magnesium levels; urinary protein excretion; body mass index (BMI), waist-to-hip ratio (WHR), and blood pressure. RESULTS: The presence of CRP was documented in four (2.9%) lean, 13 (9.8%) overweight, and 20 (20.0%) obese subjects, and decreased magnesium levels (equal or less than 1.8 mg=dl), in 2 (1.45%) lean, 7 (5.2%) overweight, and 19 (19%) obese subjects. The lowest serum magnesium levels and the highest CRP concentrations were documented in the obese subjects. Twenty-three (82.1%) of the subjects with low serum magnesium (five overweight and 18 obese) showed CRP concentration equal or more than 10 mg=l. There was a graded significant decrease between CRP concentration and serum magnesium levels (r ¼ 70.39, P ¼ 0.002). The odds ratio (CI 95% ) between magnesium and CRP adjusted by age, sex, BMI and glucose tolerance status for the subjects within the low quartile of magnesium distribution was 2.11 (1.23 -3.84).
Introduction
The increase of several serum proteins named acute phase reactants is a feature of the tissue response to inflammation. 1 Recently, it has been proposed that the acute-phase reaction could play an important role in the pathophysiology of the metabolic syndrome and type 2 diabetes. 2 -4 C-reactive protein (CRP) is one of the most sensitive acute-phase reactants in humans, 5 its elevated serum levels are a precise index of inflammatory activity, and have been related with coronary heart disease, 6 -11 dyslipidemia, 12, 13 and obesity, 14 -17 supporting the hypothesis that inflammation plays a role in the development of metabolic syndrome and diabetes.
On the other hand, magnesium is an essential ion for many enzymatic reactions, especially those using highenergy phosphate bounds. 18, 19 The low serum magnesium levels are associated with coronary heart disease, 20, 21 atherosclerosis, 22 dyslipidemia. 23, 24 and high blood pressure. 22 These findings suggest that hypomagnesemia could be involved in the pathogenesis of cardiovascular disease, 22 insulin resistance, 25 -27 and type 2 diabetes. 28 Although the experimental magnesium deficiency in rats induces an exacerbated immune stress response 29 that increase the levels of acute-phase reactants, the significance of this finding has received little attention.
Because hypomagnesemia and the inflammatory response seem to be linked, and both are related to the development of glucose metabolic disorders, we examined the relationship between serum magnesium levels and CRP concentration in non-diabetic, non-hypertensive obese subjects.
Methods
We included 371 non-diabetic, non-hypertensive subjects in a cross-sectional population based study that compared obese vs overweight and lean individuals, matched by age and sex. All individuals are participants in an ongoing prospective study to analyze the pathogenesis of type 2 diabetes and insulin resistance. Eligible subjects were recruited between November 1998 and December 2000. With the approval by the Mexican Social Security Institute Scientific Research Committee, inhabitants of Durango, a city in the north of Mexico, were randomly recruited to participate in the prospective study according to two-stage cluster sampling, as has been previously described. 30 All the subjects gave informed consent.
Pregnancy, alcohol consumption, cigarette smoking, diagnosis of diabetes, high blood pressure, cardiovascular and coronary heart disease, renal disease, chronic disorders of the joints and connective tissues, acute infectious diseases including periodontal and urinary infections, and malignancy were exclusion criteria. All the subjects were carefully questioned, clinically examined, and laboratory tested to determine the presence of exclusion criteria.
Diagnosis criteria
Low serum magnesium levels were defined as a fasting serum magnesium value of 1.8 mg=dl or less, equivalent to the low quartile of distribution of the studied cohort.
Obesity was defined by both body mass index (BMI) ! 30 kg=m 2 and waist-to-hip ratio (WHR) greater than 0.95 for men and 0.85 for women. Overweight subject were those with BMI ! 25 and < 30 kg=m 2 and WHR ! 0.85 and 0.95 for men, and ! 0.75 and 0.85 for women; lean subjects were those with BMI < 25 kg=m 2 and WHR less than 0.85 for men and 0.75 for women.
Diagnosis of impaired glucose tolerance (IGT) and diabetes was performed according to the American Diabetes Association criteria, 31 and the high blood pressure according to the VI Joint National Committee recommendation. 32 
Measurements
Anthropometric measurements, including height and weight, were taken using standard protocols. BMI was calculated as weight (in kilograms) divided by height (in meters) squared. Waist circumference was taken as the minimum circumference at umbilicus level, and hip circumference as the maximum circumference around the buttocks and the symphysis of pubis. WHR was calculated as waist circumference divided by hip circumference. All measurements were performed twice by the main researchers. The coefficient of variation was 1.2%.
Subjects underwent a standard 75 g oral glucose load after 10 h overnight fasting. Venous whole blood samples were drawn before and 2 h post oral glucose load. Serum glucose was measured by the glucose-oxidase method; its intra-and inter-assay variations were 2.5% and 4.0%. The lipid profile was measured by enzymatic methods; the intra-and interassay variations were 2 and 3.0%. CRP concentration was measured by automated microparticle enzyme immunoassay (IMx, Abbot Laboratories, USA). The detection limit of CRP was 0.05 mg=dl, with an intra-and inter-assay coefficients of variation of 4.1 and 5.8%, respectively. Serum magnesium concentrations were measured by colorimetric method, the intra-and inter-assay variations were 1.0 and 2.5%.
Measurements were performed in an Express 500 clinical chemistry autoanalyzer (Ciba Corning, Diagnostic Corp., Overling, OH, USA).
Statistical analysis
Differences between the groups were established by one way nested ANOVA design model. 33 Pearson's analysis was performed to examine the correlation between CRP concentration and continuous variables. For the purpose of statistical analysis, all the skewed numerical data were transformed to the Logn, which gave symmetrical distribution.
All significant variables related to the inflammatory response were included as dependent variables, and quartile distribution of magnesium levels as the independent variable in a logistic regression model, adjusted by age, sex, BMI, WHR and glucose tolerance status.
A 95% confidence interval (CI 95% ) was considered, and a P-value < 0.05 defined the level of statistical significance.
The data were analyzed using the statistical packages Stata 7.0 (StataCorp, TX, USA, 2001) and SPSS 8.0 (SPSS Inc., II, USA, 1998).
Results
Three-hundred and seventy-one subjects, 138 lean (37 men and 101 women), 133 overweight (39 men and 94 women), and 100 obese (25 men and 75 women) were included. There were no significant statistical differences by sex, P ¼ 0.790, nor age P ¼ 0.612. Table 1 shows the clinical and laboratory characteristics of the three groups studied. Obese subjects showed higher fasting and 2 h serum glucose, total-cholesterol, LDL-cholesterol, triglycerides, CRP concentration, and proteinuria, and lower serum HDL-cholesterol, albumin and magnesium levels than the overweight and lean subjects.
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The presence of CRP was documented in four (2.9%) lean, 13 (9.8%) overweight, and 20 (20.0%) obese subjects. The low and high quartiles of CRP distribution were 1.5 and 7.5 mg=l for the lean subjects, 5.0 and 12.0 mg=l for the overweight, and 5.5 and 17.5 mg=l for the obese subjects.
There was a significant positive correlation between CRP concentration and BMI, WHR and urine protein concentration, and a significant negative correlation between CRP concentration and serum albumin and magnesium levels ( Table 2) .
On the other hand, decreased levels of magnesium were documented in two (1.45%) lean, seven (5.2%) overweight, and 19 (19%) obese subjects. The lowest serum magnesium levels were documented in the obese subjects (Table 1) .
Twenty-three (82.1%) of the subjects with low serum magnesium (five overweight and 18 obese) showed CRP concentration equal or more than 10 mg=l.
Serum magnesium was inversely correlated with BMI, WHR, urine protein concentration and CRP concentration, and positively correlated with serum albumin (Table 2) .
The low and high quartiles of magnesium distribution were 2.1 and 2.5 mg=dl for the lean subjects, 2.1 and 2.3 mg=dl for the overweight, and 1.65 and 2.1 mg=dl for the obese subjects.
The odds ratio (OR) between magnesium and CRP adjusted by BMI, WHR and glucose tolerance status for all subjects, according to the quartiles distribution of the magnesium levels are shown in Table 3 . Low serum magnesium levels were an independent predictor for elevated CRP and proteinuria and decreased serum albumin.
The IGT diagnosis was established in 59 (15.9%) individuals: 7 (5.1%) lean, 21 (15.6%) overweight, and 29 (29.0%) obese subjects. The CRP concentration in glucose-intolerant obese subjects ranged from 6.5 to 21.6 mg=dl (median, 11.5), and the mean (s.d) of serum magnesium levels was 1.8 mg=dl (0.4).
Discussion
The results of this study show that low serum magnesium levels are linked to elevated CRP concentration, in nondiabetic, non-hypertensive obese subjects.
In order to control the potential confounders, to assess the specific association between CRP and obesity requires the exclusion of disorders that increase the acute-phase reactants. Thus, in this study pregnancy, alcohol consumption, cigarette smoking, diagnosis of diabetes, high blood pressure, cardiovascular and coronary heart disease, renal disease, chronic disorders of the joints and connective tissues, Serum magnesium and C-reactive protein F Guerrero-Romero and M Rodríguez-Morán and acute infectious disease were exclusion criteria. So, the acute-phase response that we documented, evident by the increase in CRP concentration and diminished serum albumin levels, seems to be the result of a low-grade inflammatory status that predominantly affected the obese subjects. In addition, in this study the degree of proteinuria, a wellrecognized cardiovascular risk factor and maybe a component of the acute-phase response, 3 also showed the highest values in obese subjects. These findings support the hypothesis that adipose tissue and endothelium could be the trigger of the acute-phase reaction in predisposed subjects. 3 The independent relationship between the low serum magnesium levels and elevated CRP concentration that our results show requires further attention in order to clarify the role of magnesium deficiency in the etiology of the inflammatory process. In this regard, recently, Malpuech-Brugere et al 34 reported that magnesium deficient rats showed a significant increase in the acute-phase reactants and reduced serum albumin, and concluded that inflammatory response is an early consequence of magnesium deficiency, suggesting that reduced extracellular magnesium might be responsible for the activated state of immune cells. The sequence of early events that produces the acute-phase response is currently unknown. However, new data related to the essential role of magnesium deficiency in the inflammatory response are emerging. 34 -37 It appears that abnormal calcium handling induced by extracellular magnesium deficiency may be the origin of an exacerbated inflammatory response, 29 and that the activated or primed state of immune cells is an early event occurring in magnesium deficiency. 37 To our knowledge there are no previous reports based on population based surveys that explore this issue, so further research is required to establish the role of hypomagnesemia on CRP production.
A related issue that needs to be explored is the potential role of hypomagnesemia and elevated CRP concentration on the pathogenesis of glucose metabolic disorders. In this regard, it is significant that both increased acute-phase response 38 and decreased serum magnesium levels 39 are related to aging, a well-known risk factor for glucose metabolic disorders and cardiovascular disease. Based on the results of this study, we can hypothesize that decreased serum magnesium levels could be the trigger of the acutephase response that releases CRP, an atherosclerotic risk factor 40, 41 which may contribute to the development of insulin resistance. 3 The potential limitations of this study deserve mention. First, our results are based on a cross-sectional study, which cannot demonstrate a cause-effect relationship. It will be necessary to conduct interventional prospective studies to demonstrate whether an increase of serum magnesium levels precedes a decrease in CRP concentrations. Second, our study was limited to measures of CRP and albumin, and we have no information on other acute-phase proteins. A decrease of serum albumin 1 and increase in CRP concentrations 5 are two of the most sensitive changes related to the acute-phase reaction. However, evaluation of specific acutephase reactants and cytokines will be necessary to add data to this issue. Third, a number of chronic infections are linked with heart disease 40, 42 and could be a source of both raised CRP concentration and decreased serum magnesium levels. In this concern, although we carefully excluded subjects with acute infectious disease and chronic disorders of the Serum magnesium and C-reactive protein F Guerrero-Romero and M Rodríguez-Morán joints and connective tissues, we did not evaluate the presence of chronic infectious disease, such as Helicobacter pylori; however, this possibility is likely to affect both groups, minimizing this potential limitation. Furthermore, it is necessary to take into account that the raised acute phase reactants in chronic infections return to the normal serum levels in a few days. 1 Thus, it seems to be unlikely that chronic infections could be the explanation for the increased CRP concentration and decreased serum magnesium levels that we documented.
This study provides evidence about the independent relationship between low serum magnesium and elevated CRP concentration in non-diabetic, non-hypertensive obese subjects. However, the sequence of events that link the decreased serum magnesium levels and raised CRP concentration remains unclear. So further research is needed in order to determine whether the inflammatory processes could be the source of decreased serum magnesium levels.
